Home
Data
Calendar
Blog
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | NA | 49.55 | 42.37 | 40.11 | NA | 38.49 | 39.55 | 37.13 | NA | 36.55 | 36.18 | 33.53 | NA | 32.37 | 30.36 | NA | NA | 30.00 | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | NA | 49.55 | 42.37 | 40.11 | NA | 38.49 | 38.24 | 37.13 | NA | 36.55 | 36.18 | 33.53 | NA | 30.53 | 30.36 | 30.19 | NA | 30.00 | NA | NA | NA | |
| Earnings Per Share Basic | -0.94 | -0.73 | -0.92 | -0.90 | -0.64 | -0.78 | 0.70 | -0.85 | -0.58 | -0.69 | -0.77 | -0.63 | -0.57 | 0.18 | -0.52 | -0.55 | -0.63 | -0.30 | NA | NA | NA | |
| Earnings Per Share Diluted | -0.94 | -0.73 | -0.92 | -0.90 | -0.64 | -0.78 | 0.68 | -0.85 | -0.58 | -0.69 | -0.77 | -0.63 | -0.57 | 0.17 | -0.52 | -0.55 | -0.63 | -0.30 | NA | NA | NA |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 0.00 | 0.00 | 0.00 | 0.52 | 6.13 | 2.06 | 60.24 | 2.38 | 9.56 | 3.12 | 3.85 | 3.27 | 5.90 | 25.76 | 7.69 | 5.59 | -0.33 | 5.67 | 5.57 | 6.07 | 3.36 | |
| Revenue From Contract With Customer Including Assessed Tax | 0.00 | 0.00 | 0.00 | 0.52 | 6.13 | 2.06 | 60.24 | 2.38 | 9.56 | 3.12 | 3.85 | 3.27 | 5.90 | 25.76 | 7.69 | 5.59 | -0.33 | 5.67 | 5.57 | 6.07 | 3.36 | |
| Revenues | 0.00 | 0.00 | 0.00 | 0.52 | 6.13 | 2.06 | 60.24 | 2.38 | 9.56 | 3.12 | 3.85 | 3.27 | 5.90 | 25.76 | 7.69 | 5.59 | -0.33 | 5.67 | 5.57 | 6.07 | 3.36 | |
| Costs And Expenses | 49.43 | 44.75 | 45.30 | 39.73 | 32.72 | 33.55 | 33.89 | 34.05 | 31.10 | 28.24 | 31.69 | 24.57 | 23.88 | 20.75 | 24.11 | 23.38 | 20.25 | 15.53 | 15.98 | 12.20 | 9.33 | |
| Research And Development Expense | 39.85 | 34.36 | 35.72 | 30.45 | 24.70 | 25.25 | 25.65 | 26.46 | 23.66 | 20.97 | 24.55 | 18.61 | 18.75 | 16.00 | 19.92 | 18.96 | 16.82 | 12.63 | 13.91 | 10.37 | 7.29 | |
| General And Administrative Expense | 9.58 | 10.38 | 9.58 | 9.28 | 8.01 | 8.30 | 8.23 | 7.59 | 7.44 | 7.28 | 7.14 | 5.95 | 5.13 | 4.75 | 4.20 | 4.42 | 3.43 | 2.90 | 2.08 | 1.83 | 2.04 | |
| Operating Income Loss | -49.43 | -44.75 | -45.30 | -39.20 | -26.58 | -31.49 | 26.35 | -31.67 | -21.55 | -25.12 | -27.84 | -21.30 | -17.98 | 5.01 | -16.42 | -17.79 | -20.58 | -9.86 | -10.42 | -6.13 | -5.97 | |
| Interest Income Expense Nonoperating Net | 8.83 | 8.61 | 6.43 | 3.10 | 2.24 | 1.66 | 0.48 | 0.19 | 0.13 | 0.08 | 0.04 | 0.03 | 0.11 | 0.23 | 0.41 | 0.89 | 1.09 | 1.39 | 1.12 | 1.06 | 0.66 | |
| Allocated Share Based Compensation Expense | 10.52 | 10.53 | 10.31 | 9.58 | 7.12 | 7.54 | 7.62 | 6.76 | 5.64 | 5.79 | 5.31 | 4.44 | 3.02 | 3.00 | 2.49 | 2.54 | 1.38 | 0.99 | 0.67 | 0.50 | 0.60 | |
| Income Tax Expense Benefit | 0.13 | 0.08 | 0.14 | 0.03 | 0.04 | 0.03 | 0.00 | NA | NA | NA | NA | NA | -0.14 | -0.12 | -0.15 | -0.16 | 0.34 | 0.30 | 0.14 | 0.13 | 0.00 | |
| Profit Loss | -40.73 | -36.21 | -39.01 | -36.13 | -24.38 | -30.02 | 26.84 | -31.48 | -21.40 | -25.04 | -27.82 | -21.28 | -17.75 | 5.35 | -15.86 | -16.75 | -19.83 | -8.86 | -9.43 | -5.20 | NA | |
| Other Comprehensive Income Loss Net Of Tax | 4.00 | 0.20 | -0.23 | 1.65 | 0.76 | -1.68 | -0.62 | -1.31 | -0.39 | -0.07 | -0.00 | 0.01 | -0.06 | -0.19 | -0.39 | 0.57 | -0.00 | 0.01 | 0.02 | 0.03 | NA | |
| Net Income Loss | -40.73 | -36.21 | -39.01 | -36.13 | -24.38 | -30.02 | 26.84 | -31.48 | -21.40 | -25.04 | -27.82 | -21.28 | -17.75 | 5.35 | -15.86 | -16.75 | -19.83 | -8.86 | -9.43 | -5.20 | -5.34 | |
| Comprehensive Income Net Of Tax | -36.73 | -36.01 | -39.24 | -34.48 | -23.62 | -31.70 | 26.22 | -32.79 | -21.79 | -25.11 | -27.82 | -21.28 | -17.80 | 5.16 | -16.25 | -16.18 | -19.83 | -8.86 | -9.42 | -5.17 | -5.34 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 722.51 | 743.60 | 748.72 | 441.95 | 368.59 | 389.18 | 413.88 | 397.07 | 426.29 | 438.56 | 439.48 | 459.57 | 242.38 | 221.58 | 212.00 | 229.16 | 247.44 | 260.08 | 178.61 | NA | 189.31 | |
| Liabilities | 25.49 | 20.43 | 19.36 | 15.43 | 19.47 | 24.12 | 25.89 | 83.70 | 89.59 | 88.40 | 91.57 | 90.67 | 97.19 | 91.27 | 97.08 | 101.02 | 106.52 | 100.73 | 104.78 | NA | 102.05 | |
| Liabilities And Stockholders Equity | 722.51 | 743.60 | 748.72 | 441.95 | 368.59 | 389.18 | 413.88 | 397.07 | 426.29 | 438.56 | 439.48 | 459.57 | 242.38 | 221.58 | 212.00 | 229.16 | 247.44 | 260.08 | 178.61 | NA | 189.31 | |
| Stockholders Equity | 697.02 | 723.17 | 729.36 | 426.51 | 349.12 | 365.06 | 387.99 | 313.37 | 336.70 | 350.17 | 347.91 | 368.89 | 145.20 | 130.30 | 114.92 | 128.13 | 140.92 | 159.35 | -65.98 | -57.23 | -52.55 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 716.93 | 738.10 | 742.62 | 435.75 | 362.18 | 382.41 | 406.62 | 389.49 | 418.33 | 435.40 | 436.85 | 456.85 | 239.44 | 218.40 | 208.61 | 225.55 | 243.57 | 257.04 | 172.79 | NA | 187.12 | |
| Cash And Cash Equivalents At Carrying Value | 58.58 | 74.23 | 217.28 | 41.90 | 59.27 | 84.96 | 141.18 | 119.84 | 171.43 | 184.16 | 399.40 | 395.99 | 102.05 | 98.08 | 133.12 | 107.03 | 101.56 | 159.81 | 44.20 | 42.42 | 185.90 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 59.14 | 74.79 | 217.84 | 42.46 | 59.83 | 85.52 | 141.74 | 120.40 | 171.99 | 184.72 | 399.68 | 396.26 | 102.32 | 98.36 | 133.40 | 107.31 | 101.83 | 160.08 | 44.47 | 42.69 | 186.18 | |
| Prepaid Expense And Other Assets Current | 12.58 | 13.03 | 11.27 | 13.96 | 13.48 | 9.99 | 8.02 | 6.80 | 7.89 | 5.21 | 3.91 | 5.77 | 3.86 | 3.62 | 2.54 | 2.86 | 3.09 | 2.93 | 1.44 | NA | 1.22 | |
| Available For Sale Securities Debt Securities | 645.77 | 650.84 | 514.08 | 379.38 | 288.98 | 286.80 | 256.38 | 260.81 | 236.70 | 243.42 | NA | NA | 126.22 | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 9.04 | NA | NA | NA | 7.30 | NA | NA | NA | 6.76 | NA | NA | NA | 5.76 | NA | NA | NA | 5.47 | NA | NA | NA | 3.05 | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 6.27 | NA | NA | NA | 5.18 | NA | NA | NA | 4.18 | NA | NA | NA | 3.15 | NA | NA | NA | 2.03 | NA | NA | NA | 1.21 | |
| Property Plant And Equipment Net | 2.77 | 2.28 | 2.51 | 2.24 | 2.12 | 2.17 | 2.37 | 2.37 | 2.58 | 2.58 | 2.33 | 2.39 | 2.61 | 2.82 | 3.02 | 3.22 | 3.45 | 2.72 | 2.53 | NA | 1.84 | |
| Other Assets Noncurrent | 0.13 | 0.18 | 0.20 | 0.23 | 0.21 | 0.20 | 0.15 | 0.16 | 0.01 | 0.01 | 0.03 | 0.05 | 0.07 | 0.09 | 0.09 | 0.11 | 0.14 | 0.05 | 3.02 | NA | 0.06 | |
| Available For Sale Debt Securities Amortized Cost Basis | 643.46 | 652.53 | 515.97 | 381.04 | 292.29 | 290.87 | 258.77 | 262.58 | 237.16 | 243.48 | NA | NA | 126.21 | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 24.78 | 19.30 | 17.81 | 13.48 | 17.13 | 18.59 | 19.68 | 43.79 | 38.26 | 41.76 | 34.91 | 34.07 | 39.44 | 35.58 | 45.28 | 36.84 | 35.35 | 26.48 | 43.53 | NA | 34.90 | |
| Accounts Payable Current | 7.70 | 5.27 | 3.66 | 5.48 | 3.48 | 4.37 | 3.88 | 3.50 | 4.80 | 3.18 | 5.25 | 2.27 | 3.85 | 3.02 | 3.88 | 4.62 | 5.17 | 3.29 | 2.91 | NA | 1.75 | |
| Accounts Payable And Accrued Liabilities Current | 17.08 | 14.03 | 14.15 | 8.00 | 13.18 | 10.87 | 11.35 | 9.99 | 12.84 | 8.42 | 7.69 | 7.20 | 10.16 | 7.46 | 8.29 | 5.62 | 6.64 | 5.05 | 5.22 | NA | 3.24 | |
| Accrued Liabilities Current | 1.10 | 1.01 | 0.98 | 0.75 | 0.85 | 0.78 | 1.48 | 0.94 | 0.96 | 1.01 | 0.97 | 1.25 | 0.68 | 0.96 | 0.82 | 0.72 | 1.01 | 1.17 | 1.68 | NA | 0.71 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | 0.72 | 1.14 | 1.55 | 1.95 | 2.34 | 2.73 | 3.11 | 3.48 | 3.84 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 697.02 | 723.17 | 729.36 | 426.51 | 349.12 | 365.06 | 387.99 | 313.37 | 336.70 | 350.17 | 347.91 | 368.89 | 145.20 | 130.30 | 114.92 | 128.13 | 140.92 | 159.35 | -65.98 | -57.23 | -52.55 | |
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | NA | NA | NA | NA | |
| Additional Paid In Capital | 1143.92 | 1133.33 | 1103.52 | 761.43 | 649.55 | 641.87 | 633.10 | 584.69 | 575.23 | 566.91 | 539.54 | 532.70 | 287.73 | 255.03 | 244.81 | 241.78 | 238.38 | 236.98 | 2.80 | NA | 1.63 | |
| Retained Earnings Accumulated Deficit | -449.19 | -408.45 | -372.24 | -333.23 | -297.10 | -272.72 | -242.70 | -269.54 | -238.05 | -216.65 | -191.61 | -163.80 | -142.51 | -124.76 | -130.12 | -114.26 | -97.51 | -77.68 | -68.82 | NA | -54.19 | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | 2.29 | -1.72 | -1.92 | -1.69 | -3.34 | -4.10 | -2.42 | -1.79 | -0.48 | -0.09 | -0.02 | -0.02 | -0.02 | 0.03 | 0.22 | 0.61 | 0.04 | NA | NA | NA | NA |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -28.57 | -29.25 | -23.03 | -31.45 | -25.12 | -24.89 | -22.82 | -28.15 | -20.59 | -24.58 | -17.91 | -20.39 | -14.42 | 3.73 | -16.36 | -18.94 | -14.07 | -13.70 | -14.07 | 0.19 | 92.56 | |
| Net Cash Provided By Used In Investing Activities | 12.88 | -133.08 | -133.22 | -88.40 | -1.15 | -32.51 | 3.28 | -26.07 | 5.19 | -211.96 | 19.85 | 73.75 | -11.29 | -46.05 | 41.91 | 23.62 | -44.20 | 34.20 | 17.68 | -143.67 | -0.16 | |
| Net Cash Provided By Used In Financing Activities | 0.03 | 19.29 | 331.63 | 102.48 | 0.57 | 1.18 | 40.88 | 2.63 | 2.67 | 21.58 | 1.48 | 240.58 | 29.68 | 7.28 | 0.54 | 0.80 | 0.03 | 95.10 | NA | NA | -0.41 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -28.57 | -29.25 | -23.03 | -31.45 | -25.12 | -24.89 | -22.82 | -28.15 | -20.59 | -24.58 | -17.91 | -20.39 | -14.42 | 3.73 | -16.36 | -18.94 | -14.07 | -13.70 | -14.07 | 0.19 | 92.56 | |
| Net Income Loss | -40.73 | -36.21 | -39.01 | -36.13 | -24.38 | -30.02 | 26.84 | -31.48 | -21.40 | -25.04 | -27.82 | -21.28 | -17.75 | 5.35 | -15.86 | -16.75 | -19.83 | -8.86 | -9.43 | -5.20 | -5.34 | |
| Profit Loss | -40.73 | -36.21 | -39.01 | -36.13 | -24.38 | -30.02 | 26.84 | -31.48 | -21.40 | -25.04 | -27.82 | -21.28 | -17.75 | 5.35 | -15.86 | -16.75 | -19.83 | -8.86 | -9.43 | -5.20 | NA | |
| Increase Decrease In Accounts Receivable | 0.00 | 0.00 | -0.51 | 0.05 | -0.21 | -0.37 | -1.00 | -0.27 | -0.31 | 1.30 | -1.45 | -4.55 | 5.68 | -1.90 | -0.15 | 0.22 | 1.10 | 1.42 | 0.57 | 0.38 | NA | |
| Increase Decrease In Accounts Payable | 1.79 | 1.60 | -1.66 | 2.00 | -1.03 | 0.50 | 0.28 | -1.30 | 1.81 | -2.22 | 2.94 | -1.57 | 0.82 | -0.84 | -0.74 | -0.31 | 1.62 | 0.38 | 0.02 | 1.14 | -0.00 | |
| Share Based Compensation | 10.52 | 10.53 | 10.31 | 9.58 | 7.12 | 7.54 | 7.62 | 6.76 | 5.64 | 5.79 | 5.31 | 4.44 | 3.02 | 3.00 | 2.49 | 2.54 | 1.38 | 0.99 | 0.67 | 0.50 | 0.60 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | 12.88 | -133.08 | -133.22 | -88.40 | -1.15 | -32.51 | 3.28 | -26.07 | 5.19 | -211.96 | 19.85 | 73.75 | -11.29 | -46.05 | 41.91 | 23.62 | -44.20 | 34.20 | 17.68 | -143.67 | -0.16 | |
| Payments To Acquire Property Plant And Equipment | 0.09 | 0.30 | 0.29 | 0.55 | 0.06 | 0.25 | 0.00 | 0.05 | 0.46 | 0.36 | 0.15 | 0.05 | 0.07 | 0.09 | 0.09 | 0.29 | 0.71 | 0.39 | 0.50 | 0.56 | 0.17 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 0.03 | 19.29 | 331.63 | 102.48 | 0.57 | 1.18 | 40.88 | 2.63 | 2.67 | 21.58 | 1.48 | 240.58 | 29.68 | 7.28 | 0.54 | 0.80 | 0.03 | 95.10 | NA | NA | -0.41 |
| 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 0.00 | 0.00 | 0.00 | 0.52 | 6.13 | 2.06 | 60.24 | 2.38 | 9.56 | 3.12 | 3.85 | 3.27 | 5.90 | 25.76 | 7.69 | 5.59 | -0.33 | 5.67 | 5.57 | 6.07 | 3.36 | |
| Janssen Pharmaceuticals Inc, Reimbursement Revenue | 0.00 | 0.00 | 0.00 | 0.05 | 0.46 | 0.66 | 1.03 | 1.01 | 1.03 | 1.28 | 1.31 | 1.32 | 1.44 | 1.63 | 1.84 | NA | NA | NA | NA | NA | NA | |
| Janssen Pharmaceuticals Inc, Upfront Payment Revenue | 0.00 | 0.00 | 0.00 | 0.47 | 5.32 | 0.50 | 0.76 | 0.56 | 2.37 | 0.37 | 0.47 | 0.44 | 0.74 | 0.48 | 0.56 | NA | NA | NA | NA | NA | NA | |
| Janssen Pharmaceuticals Inc, License | 0.00 | 0.00 | 0.00 | 0.52 | 5.78 | 1.17 | 1.79 | 1.57 | 3.40 | 1.65 | 1.78 | 1.77 | 2.17 | 2.11 | 2.40 | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 0.00 | 0.00 | 0.00 | 0.52 | 6.13 | 2.06 | 60.24 | 2.38 | 9.56 | 3.12 | 3.85 | 3.27 | 5.90 | 25.76 | 7.69 | 5.59 | -0.33 | 5.67 | 5.57 | 6.07 | 3.36 | |
| Janssen Pharmaceuticals Inc, Reimbursement Revenue | 0.00 | 0.00 | 0.00 | 0.05 | 0.46 | 0.66 | 1.03 | 1.01 | 1.03 | 1.28 | 1.31 | 1.32 | 1.44 | 1.63 | 1.84 | NA | NA | NA | NA | NA | NA | |
| Janssen Pharmaceuticals Inc, Upfront Payment Revenue | 0.00 | 0.00 | 0.00 | 0.47 | 5.32 | 0.50 | 0.76 | 0.56 | 2.37 | 0.37 | 0.47 | 0.44 | 0.74 | 0.48 | 0.56 | NA | NA | NA | NA | NA | NA | |
| Janssen Pharmaceuticals Inc, License | 0.00 | 0.00 | 0.00 | 0.52 | 5.78 | 1.17 | 1.79 | 1.57 | 3.40 | 1.65 | 1.78 | 1.77 | 2.17 | 2.11 | 2.40 | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Including Assessed Tax | 0.00 | 0.00 | 0.00 | 0.52 | 6.13 | 2.06 | 60.24 | 2.38 | 9.56 | 3.12 | 3.85 | 3.27 | 5.90 | 25.76 | 7.69 | 5.59 | -0.33 | 5.67 | 5.57 | 6.07 | 3.36 |
